Unicycive Therapeutics (UNCY) Assets (2020 - 2026)
Unicycive Therapeutics' Assets was $72.03 million in Q2 2026, up 140.1% from $30 million a year earlier and up 11.8% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Assets at Unicycive Therapeutics came in at $49.14 million, up 55.2% from FY2024.
- Assets has now increased for three consecutive years, with a five-year compound annual growth rate of 199.5% (FY2020 to FY2025).
- In earlier years, Assets was $31.67 million in FY2024 (+123.2%), $14.19 million in FY2023 (+403.6%), $2.82 million in FY2022 (-85.0%) and $18.74 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Assets in data going back to Q4 2020.
- Compared with a year earlier, Assets has increased for four straight quarters, with growth averaging 62.4% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2023 (growth of 403.6%); the worst was Q4 2022 (a decline of 85.0%).
- Per Business Quant data, UNCY's Assets in the three quarters before Q2 2026 was $64.41 million (Q1 2026), $49.14 million (Q4 2025) and $50.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Unicycive Therapeutics | 104.17 Mn | -95.81 Mn | - | 72.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.03 Mn |
| Mar 31, 2026 | 64.41 Mn |
| Dec 31, 2025 | 49.14 Mn |
| Sep 30, 2025 | 50.61 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Mar 31, 2025 | 27.95 Mn |
| Dec 31, 2024 | 31.67 Mn |
| Sep 30, 2024 | 38.57 Mn |
| Jun 30, 2024 | 44.70 Mn |
| Mar 31, 2024 | 52.39 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 19.44 Mn |
| Jun 30, 2023 | 22.88 Mn |
| Mar 31, 2023 | 27.20 Mn |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | 10.18 Mn |
| Jun 30, 2022 | 12.82 Mn |
| Mar 31, 2022 | 15.76 Mn |
| Dec 31, 2021 | 18.74 Mn |
| Sep 30, 2021 | 19.78 Mn |
API Access
Unicycive Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();